Revlon Q4 and 2006
This article was originally published in The Rose Sheet
Executive Summary
Lower shipments of color cosmetics resulted in a 20.7% plunge in U.S. sales to $227.1 mil. for the fiscal year 2006 fourth quarter (ended Dec. 31), Revlon announces March 13. International sales remained flat at $151.8 mil., as low-single-digit declines in Asia Pacific and Europe offset double-digit growth in Latin America, firm says. Overall, Q4 sales dropped 13.5% from the prior-year period to $378.9 mil., as the firm continues its "organizational streamlining" following the September discontinuance of Vital Radiance. For the full year, sales were flat at $1.33 bil. Domestic sales declined 3% to $764.9 mil., with higher sales of Revlon and Almay partially compensating for the Vital Radiance discontinuance. Internationally, sales grew 4.1% to $566.5 mil. on higher shipments in Europe and Latin America. Net loss in 2006 was $251.3 mil., compared with a net loss of $83.7 mil. in 2005. "Our results for the year reflect the important and costly decisions we have made to position Revlon for future success," Revlon President and CEO David Kennedy said, adding that the firm plans to focus on improving profitability and cash flow in 2007...
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.